NABRIVA THERAPEUTICS PLC (NBRV) Stock Analyst Ratings
NASDAQ:NBRV - Nasdaq - IE000OZRGNV6 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 40% to NBRV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is -28.17% below the current price.
NBRV was analyzed by 6 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about NBRV.
In the previous month the buy percentage consensus was at a similar level.
NBRV was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-09-16 | Northland Capital Markets | Maintains | Outperform |